These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1706927)
21. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Rosenberg SA; Lotze MT; Yang JC; Aebersold PM; Linehan WM; Seipp CA; White DE Ann Surg; 1989 Oct; 210(4):474-84; discussion 484-5. PubMed ID: 2679456 [TBL] [Abstract][Full Text] [Related]
22. Review article: biological agents in the treatment of Crohn's disease. Caprilli R; Viscido A; Guagnozzi D Aliment Pharmacol Ther; 2002 Sep; 16(9):1579-90. PubMed ID: 12197837 [TBL] [Abstract][Full Text] [Related]
23. Cytokines and cancer. Malik S; Waxman J BMJ; 1992 Aug; 305(6848):265-7. PubMed ID: 1382767 [No Abstract] [Full Text] [Related]
24. [Cytokines as immunotherapy in cancer]. van der Schelling GP; Ijzermans JN; Marquet RL; Jeekel J Ned Tijdschr Geneeskd; 1992 Apr; 136(14):681-5. PubMed ID: 1373229 [No Abstract] [Full Text] [Related]
32. Cytokines and immunological monitoring. Kopp WC; Holmlund JT Cancer Chemother Biol Response Modif; 1996; 16():189-238. PubMed ID: 8639383 [No Abstract] [Full Text] [Related]
33. Lymphokines and cytokines. Wagstaff J; Melief K Cancer Chemother Biol Response Modif; 1988; 10():416-33. PubMed ID: 2484321 [No Abstract] [Full Text] [Related]
34. [Receptor-mediated cancer therapy--tumoricidal cytokines, adoptive therapy of LAK, TIL]. Niitsu Y; Watanabe N; Kondo H; Kanisawa Y Gan To Kagaku Ryoho; 1990 Jun; 17(6):1134-41. PubMed ID: 1693487 [TBL] [Abstract][Full Text] [Related]
35. Future perspectives for biological response modifiers: a viewpoint. Mihich E Semin Oncol; 1986 Jun; 13(2):234-54. PubMed ID: 2424090 [No Abstract] [Full Text] [Related]
36. [Immunotherapy of cancer using cytokinins. Use and perspectives in lung oncology]. Moro D; Goy A; Nagy-Mignotte H; Brambilla C Rev Mal Respir; 1990; 7(3):195-201. PubMed ID: 1694591 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic properties of biological response modifiers. A discussion of preclinical and clinical studies. Talmadge JE Contrib Gynecol Obstet; 1989; 17():49-62. PubMed ID: 2495895 [No Abstract] [Full Text] [Related]
38. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
39. Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. Atzpodien J; Kirchner H Klin Wochenschr; 1990 Jan; 68(1):1-11. PubMed ID: 2407894 [TBL] [Abstract][Full Text] [Related]